Objective To observe the changes of plasma von Willebrand factor (vWF) and soluble E-selectin (sE-selectin) in patients with coronary artery disease (CAD) and evaluate their clinic significance.
英
美
- 目的：檢測冠心病患者血漿血管性血友病因子(von Willebrand factor, vWF)及可溶性E-選擇素(sol-uble E-selectin, sE-selectin)的變化，探討其在冠心病發(fā)病機制、病情診治及監測中的意義。
